Larvol Delta - A-study-of-the-safety-and-effectiveness-of-lirentelimab-as-a-treatment-for-people-with-indolent-systemic-mastocytosis

lirentelimab (AK002) - Allakos

http://www.ncbi.nlm.nih.gov/pubmed/37879742

Oct 26, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next